CREBBP and acute lymphoblastic leukemia: ZNF384 rearrangement is common in ALL. High expression of ZNF384 is associated with poor survival in MLL and B‐ALL. Several ZNF384 fusions have been identified, including EP300‐ZNF384, CREBBP‐ZNF384, TCF3‐ZNF384, TCF4‐ZNF384, TAF15‐ZNF384, and EWSR1‐ZNF384.